| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of CDR2 mRNA | affects expression | 17562736
|
| D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of CDR2 mRNA | decreases expression | 17942131
|
| D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 18164116
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CDR2 mRNA | decreases expression | 17942131
|
| C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in decreased expression of CDR2 mRNA | decreases expression | 17942131
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CDR2 mRNA | increases expression | 20106945
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CDR2 mRNA | decreases expression | 17942131
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 18164116
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CDR2 mRNA | increases expression | 17942748 17555576
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 17942748
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 17183730
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of CDR2 mRNA | affects expression | 17555576
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CDR2 mRNA | increases expression | 17942748
|
| D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of CDR2 mRNA | increases expression | 17982090
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CDR2 mRNA | affects cotreatment|increases expression | 17183730
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.72 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.83 | 15322242 14514962 11752688 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.83 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.04 | 19490988 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.26 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.26 | 14692618 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.57 | 6695378 |
| MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.57 | 19389873 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.57 | 10737359 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.58 | 16434500 19052882 19061943 17620307 18056438 17162532 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.58 | 16835633 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.41 | 17688650 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.66 | 17497229 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17157402 16609825 18316065 15238991 17507914 18775368 18985861 18940202 18558336 18177632 19460635 20603192 19232924 17688650 18396377 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.13 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.25 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.25 | 8888407 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.93 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.93 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19189210 11161223 18815881 15668708 19200415 16202921 21152245 20544844 19084267 18425577 20859285 20005174 17893378 18984771 19221464 19103187 19011961 18855134 19189212 19142967 16873071 19115204 19487384 18351453 19066611 19289846 17440819 19155303 17261762 15565566 19244106 18629630 16818667 20135344 20390343 18997820 20065188 19410462 21138602 19288272 16273361 19059307 18821012 17049068 17242785 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.64 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.62 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.62 | 18665156 10672840 19335982 16288022 17162532 17173139 17761372 20514400 17428255 16502159 20935162 17138121 18971187 19171122 18691550 17978847 16779866 16328049 19822196 19539802 18210153 17055752 19107877 18788625 19052882 20727157 19394651 18506893 19519916 16878318 18494052 19701751 3581430 18978308 20007298 19208518 19383236 19919837 3084413 16569478 20432363 16830150 10737359 16540662 18785209 16935385 20084675 16698587 20101231 18056438 11831363 20214788 20512989 18393292 19418558 16681979 16807293 20524982 21159647 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.62 | 16924424 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.72 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18850075 18670907 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.64 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.85 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.85 | 17174075 7505956 2727394 21159647 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.74 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.65 | 19052882 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.65 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.05 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.05 | 17110522 16105132 17681005 16919318 17333356 15861022 11677210 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 15668235 8697196 15340226 12621046 |
| MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
4.68 | 17991707 16804969 16867261 16782535 11698051 16474422 17936198 18200517 18023891 |
| MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.47 | 17276891 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 20055451 10048152 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.50 | 8888407 17688650 16575769 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.50 | 19031437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.30 | 20387270 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.30 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.57 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.21 | 12540782 10915739 11743745 12153990 19420014 17906064 11739529 10663392 12594235 11287661 19164858 19739265 11529661 17562736 14550746 12705907 15619225 16109766 16393943 14986274 2444490 11834606 19923254 10774834 18713872 16177239 11461765 19370779 12958197 16081117 17522070 14725611 19416960 19085960 16485898 16227642 16781746 11421492 15968718 12392966 18071297 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.21 | 19107877 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.21 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.21 | 1733752 19641884 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.17 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 18230668 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.37 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.37 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.11 | 17893378 16202921 20544844 19155303 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.29 | 3659116 17275665 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.09 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.99 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.68 | 6426943 6254150 7562514 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.44 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.22 | 3659116 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.29 | 16302075 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.90 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
25.90 | 20387270 21071580 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.90 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
25.90 | 14986274 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
25.90 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.30 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.06 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.26 | 8888407 18558336 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.68 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.34 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.67 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.67 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
15.67 | 17994277 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 11294989 10048152 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 12621046 16120746 15340226 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.02 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 16959395 16354765 8697196 18606429 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.79 | 16870215 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18850075 18670907 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.76 | 16612254 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.59 | 18785209 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.59 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.59 | 12200463 12878042 |
| MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.61 | 18200517 |
| MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.74 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.99 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.99 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.61 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.61 | 18625569 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 16294345 17596541 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.23 | 15342952 17567588 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.88 | 18407596 18522880 20032147 19638242 18665156 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.31 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.99 | 19014921 16611625 12969438 16610002 19460945 11587558 19784758 12587719 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.99 | 17034775 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 16871587 17185352 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.66 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
14.66 | 19389873 21295105 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.66 | 19254457 20492335 15175105 18978307 20583210 20501860 20101389 19090486 18648771 2422723 21071580 20405173 19996281 19850985 19255062 20434301 21167192 20118626 15885732 18754104 19642983 19427195 2862719 19256749 18977376 9163691 20137499 16942905 12771043 19073162 19294768 19551842 19690152 20452335 19812893 21047994 12112319 18644402 19426721 10737359 21278145 19833225 19499222 19638242 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.66 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.66 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.25 | 18164116 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.25 | 19009564 3124819 16267830 18079962 19539802 18093689 18282651 18775883 16842330 19004024 9362446 17174075 19519916 21159647 18308698 19126423 17942915 2563599 17854601 18253720 18164116 18544905 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.25 | 12151625 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.44 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.91 | 20464547 17053015 18816296 18520028 18569708 6695378 20064080 20135361 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.91 | 20970405 6695378 20512841 21163286 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.91 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.91 | 19555203 11884234 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.91 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.69 | 14580682 19196722 11731420 16827153 19196723 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.72 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.89 | 19393235 12393984 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.34 | 15990972 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.27 | 18765137 18803445 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.14 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.21 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.86 | 3581430 9029167 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.86 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.22 | 11141357 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.17 | 19196722 19200415 19189210 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.20 | 16359493 8888407 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.49 | 18514411 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.49 | 20387270 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.29 | 20387270 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.48 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
| MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.32 | 17698068 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.27 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.27 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.98 | 11399792 11896295 11222880 11118676 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.98 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.10 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.71 | 12752131 11422049 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.29 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
2.81 | 11044598 15475178 11738929 16876388 1511512 14763951 3137016 17978042 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.63 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.15 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.15 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.19 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.86 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.71 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.35 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.35 | 18456281 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.07 | 7505956 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.41 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.67 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.13 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.13 | 16712894 8653321 17572228 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.78 | 8888407 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |